WebMar 14, 2024 · The FDA has guidance regarding the correction of misinformation about prescription drugs and medical devices on social media coming from independent third-parties. The company’s communication should be relevant, responsive, limited, tailored, accurate, and non‑promotional in nature, tone, and presentation to the misinformation. WebMar 13, 2014 · On January 13, 2014, FDA issued a portion of its long-awaited social media guidance titled “Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics“. Although industry is likely to seek clarification and revision on certain of the rules-of-the ...
The Evolution of FDA’s Social Media Guidance—What’s Next
WebSep 20, 2024 · Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics *DRAFT* (Posted 1/14/2014) Responding to ... kim scott new book
Promotional Media Definition Law Insider
WebSep 30, 2024 · However, the widespread use of the internet and social media has added increasing complexity to the issue for the agency as well as for FDA-regulated industries. In 2014, the FDA issued three draft guidance documents, none of which have yet been finalized. Although these were applicable only to prescription human and animal drugs … WebDec 18, 2024 · Draft Guidance – January 2014 Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics [Hot Link] … WebSep 25, 2015 · In January and June 2014, FDA issued three draft guidance documents intended to describe its “current thinking” on how pharmaceutical companies may use certain aspects of social media. 2 The first guidance details whether and how a firm should submit “interactive promotional media” to FDA in order to meet its postmarketing … kim scott school board